Genetic Variants at 1p11.2 and Breast Cancer Risk: A Two-Stage Study in Chinese Women

• Yue Jiang ,

  Contributed equally to this work with: Yue Jiang, Hao Shen

  Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯
• Hao Shen ,

  Contributed equally to this work with: Yue Jiang, Hao Shen

  Affiliation MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China

  ⨯
• Xiao'an Liu,

  Affiliation Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  ⨯
• Juncheng Dai,

  Affiliation MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China

  ⨯
• Guangfu Jin,

  Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯
• Zhenzhen Qin,

  Affiliation MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China

  ⨯
• Jiaping Chen,

  Affiliations MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯
• Shui Wang,

  Affiliation Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

  ⨯
• Xinru Wang,

  Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China

  ⨯
• Zhibin Hu,

  Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯
• Hongbing Shen

  * E-mail: hongbingshen@gmail.com

  Affiliations State Key Laboratory of Reproductive Medicine, Institute of Toxicology, Nanjing Medical University, Nanjing, China, MOE Key Laboratory of Modern Toxicology, School of Public Health, Nanjing Medical University, Nanjing, China, Section of Clinical Epidemiology, Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Cancer Center, Nanjing Medical University, Nanjing, China

  ⨯